Sitaphage Tablets 50/1000Mg – Sitagliptin & Metformin for Type 2 DiabetesSitaphage 50 1000Mg Tablets Sitaphage 50 1000Mg Tablets combine Sitagliptin 50mg, a DPP 4 inhibitor, with Metformin HCl 1000mg, a biguanide, to provide effective glycemic control in patients with type 2 diabetes mellitus. Sitagliptin acts by inhibiting the breakdown of incretin hormones such as GLP 1 and GIP, which enhances insulin secretion in response to meals, reduces glucagon levels, and slows gastric emptying. Metformin decreases hepatic glucose